EUVIMEDEUVIMED entdecken
Crossref

A High‐Throughput Platform Utilizing FPBG‐PITC for Amino‐Containing Metabolites Screening in Breast Diseases

Hongtao Tian, Wenjia Zhang, Yunhua Chen, Robert Chunhua Zhao, Jiang Zhou iD, Zhili Li iD

Small Methods · 2025

DOI: 10.1002/smtd.202500297 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Small Methods, 2025. Verfasst von Hongtao Tian und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biophysics and Structural Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences & School of Basic Medicine,…. Hauptthemen laut MEDLINE: High-Throughput Screening Assays, Breast Neoplasms, Metabolomics, Breast Diseases. Die Arbeit nennt 41 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Chinese Academy of Medical Sciences Initiative for Innovative Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Amino‐containing metabolites play essential roles in biological processes such as protein synthesis and energy metabolism, and their dysregulation is associated with disease development. Liquid biopsy, valued for its minimal invasiveness, is widely utilized in cancer detection. However, traditional methods necessitate protein and lipid removal while suffering from low throughput and sensitivity. To address these limitations, a novel magnetic chemoselective probe, Fe 3 O 4 ‐Polymers‐Cystamine‐Boclys‐Gly‐NH 2 ‐PITC (FPBG‐PITC), is synthesized, incorporating hydrophobic tags to improve metabolite detection sensitivity and chromatographic separation. Using this probe, a high‐throughput metabolic analysis platform is established, allowing efficient enrichment, purification, and quantification of serum amino‐containing metabolites with reduced costs. Through comparative analysis of serum samples from healthy controls and patients with benign or malignant breast lesions, four metabolites—asparagine, tryptophan, leucine/isoleucine, and homocitrulline—are identified as potential biomarkers for early breast disease screening, providing a novel diagnostic strategy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

High-Throughput Screening AssaysBreast NeoplasmsMetabolomicsBreast DiseasesAmino AcidsHumansFemaleBiomarkers, TumorTryptophanEarly Detection of Cancer

Stichwörter der Autor:innen

amino containing metabolitesbreast diseaseschemoselective probeshigh‐throughputmass spectrometry

Substanzen

Amino AcidsBiomarkers, TumorTryptophan

Autor:innen und Institutionen

  • Department of Biophysics and Structural Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences & School of Basic Medicine, Peking Union Medical College, Beijing, 100005, China.
  • Department of Biomedical Engineering, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences & School of Basic Medicine, Peking Union Medical College, Beijing, 100005, China.
  • Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, School of Basic Medicine, Peking Union Medical College, Beijing, 100005, China.
  • Analytical Instrumentation Center, College of Chemistry and Molecular Engineering, Peking University, Beijing, 100871, China.

ORCID-Profile: Jiang Zhou, Zhili Li

Förderung

  • National Natural Science Foundation of China
  • Chinese Academy of Medical Sciences Initiative for Innovative Medicine

Zitieren

APA

Tian, H., Zhang, W., Chen, Y., Zhao, R. C., Zhou, J., & Li, Z. (2025). A High‐Throughput Platform Utilizing FPBG‐PITC for Amino‐Containing Metabolites Screening in Breast Diseases. Small Methods. https://doi.org/10.1002/smtd.202500297

Vancouver

Tian H, Zhang W, Chen Y, Zhao RC, Zhou J, Li Z. A High‐Throughput Platform Utilizing FPBG‐PITC for Amino‐Containing Metabolites Screening in Breast Diseases. Small Methods. 2025. doi:10.1002/smtd.202500297

BibTeX
@article{Tian2025,
  author = {Tian, Hongtao and Zhang, Wenjia and Chen, Yunhua and Zhao, Robert Chunhua and Zhou, Jiang and Li, Zhili},
  title = {A High‐Throughput Platform Utilizing FPBG‐PITC for Amino‐Containing Metabolites Screening in Breast Diseases},
  journal = {Small Methods},
  year = {2025},
  doi = {10.1002/smtd.202500297}
}
Kostenlos starten →